Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Events

Human herpesvirus-6 encephalitis following allogeneic hematopoietic stem cell transplantation

Bone Marrow Transplantation volume 39, pages 705–709 (2007)Cite this article

Abstract

Immunosuppressive monoclonal antibodies directed to immune system cells may reduce rejection and graft versus host disease (GvHD) after allogeneic stem cell transplantation (SCT), but can increase the risks of viral infection. Here, we report human herpes virus-6 (HHV-6) encephalitis despite antiviral prophylaxis in 5 of 43 (11.6%) patients receiving alemtuzumab supported conditioning. Encephalitis occurred at 41–103 days (median 60 days) presenting with confusion in all patients, combined with amnesia (n=3) or seizures (n=2). MRI revealed non-specific white matter changes in two and a non-enhancing medial temporal lobe lesion in three patients. Cerebrospinal fluid (CSF) PCR amplification for HHV-6 was positive in all five patients, (600–2 25 000 (median 4700) copies/ml CSF), while analysis of peripheral blood revealed 100–22 500 (median 1200) viral copies/ml plasma. CSF protein was elevated in four patients, with minimal CSF pleocytosis. Intravenous foscarnet produced neurological improvement at 8–13 (median 11) days and negative plasma PCR at 30–66 (median 50) days. Four patients had complete neurological recovery, but one patient with persistent viral DNA in the CSF succumbed to progressive encephalopathy. Given this high incidence of HHV-6 and the possibility of successful outcome with prompt treatment, a high index of suspicion of this disorder is required in recipients of monoclonal antibody supported allografts.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Zerr DM, Meier AS, Selke SS, Frenkel LM, Huang ML, Wald A et al. A population-based study of primary human herpesvirus 6 infection. N Engl J Med 2005; 352: 768–776.

    Article  CAS  Google Scholar 

  2. Zerr DM, Corey L, Kim HW, Huang ML, Nguy L, Boeckh M . Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. Clin Infect Dis 2005; 40: 932–940.

    Article  Google Scholar 

  3. Yamane A, Mori T, Suzuki S, Mihara A, Yamazaki R, Aisa Y et al. Risk factors for developing human herpesvirus 6 (HHV-6) reactivation after allogeneic hematopoietic stem cell transplantation and its association with central nervous system disorders. Biol Blood Marrow Transplant 2007; 13: 100–106.

    Article  CAS  Google Scholar 

  4. Drobyski WR, Knox KK, Majewski D, Carrigan DR . Brief report: fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient. N Engl J Med 1994; 330: 1356–1360.

    Article  CAS  Google Scholar 

  5. Zerr DM, Gupta D, Huang ML, Carter R, Corey L . Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34: 309–317.

    Article  CAS  Google Scholar 

  6. Kadakia MP, Rybka WB, Stewart JA, Patton JL, Stamey FR, Elsawy M et al. Human herpesvirus 6: infection and disease following autologous and allogeneic bone marrow transplantation. Blood 1996; 87: 5341–5354.

    CAS  PubMed  Google Scholar 

  7. Yoshikawa T, Asano Y, Ihira M, Suzuki K, Ohashi M, Suga S et al. Human herpesvirus 6 viremia in bone marrow transplant recipients: clinical features and risk factors. J Infect Dis 2002; 185: 847–853.

    Article  Google Scholar 

  8. Ogata M, Kikuchi H, Satou T, Kawano R, Ikewaki J, Kohno K et al. Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: incidence and clinical significance. J Infect Dis 2006; 193: 68–79.

    Article  CAS  Google Scholar 

  9. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 295–304.

    Article  CAS  Google Scholar 

  10. Reddy S, Manna P . Quantitative detection and differentiation of human herpesvirus 6 subtypes in bone marrow transplant patients by using a single real-time polymerase chain reaction assay. Biol Blood Marrow Transplant 2005; 11: 530–541.

    Article  CAS  Google Scholar 

  11. Wang LR, Dong LJ, Zhang MJ, Lu DP . The impact of human herpesvirus 6B reactivation on early complications following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2006; 12: 1031–1037.

    Article  Google Scholar 

  12. Wang FZ, Linde A, Hagglund H, Testa M, Locasciulli A, Ljungman P . Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: does it have clinical significance? Clin Infect Dis 1999; 28: 562–568.

    Article  CAS  Google Scholar 

  13. Studahl M, Hagberg L, Rekabdar E, Bergstrom T . Herpesvirus DNA detection in cerebral spinal fluid: differences in clinical presentation between alpha-, beta-, and gamma-herpesviruses. Scand J Infect Dis 2000; 32: 237–248.

    Article  CAS  Google Scholar 

  14. Cone RW, Huang ML, Corey L, Zeh J, Ashley R, Bowden R . Human herpesvirus 6 infections after bone marrow transplantation: clinical and virologic manifestations. J Infect Dis 1999; 179: 311–318.

    Article  CAS  Google Scholar 

  15. Dewhurst S . Human herpesvirus type 6 and human herpesvirus type 7 infections of the central nervous system. Herpes 2004; 11 (Suppl): 105A–111A.

    PubMed  Google Scholar 

  16. Ward KN, Leong HN, Nacheva EP, Howard J, Atkinson CE, Davies NW et al. Human herpesvirus 6 chromosomal integration in immunocompetent patients results in high levels of viral DNA in blood, sera, and hair follicles. J Clin Microbiol 2006; 44: 1571–1574.

    Article  CAS  Google Scholar 

  17. Antonini G, Ceschin V, Morino S, Fiorelli M, Gragnani F, Mengarelli A et al. Early neurologic complications following allogeneic bone marrow transplant for leukemia: a prospective study. Neurology 1998; 50: 1441–1445.

    Article  CAS  Google Scholar 

  18. Perez-Simon JA, Kottaridis PD, Martino R, Craddock C, Caballero D, Chopra R et al. Spanish and United Kingdom Collaborative Groups for Nonmyeloablative Transplantation. Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders. Blood 2002; 100: 3121–3127.

    Article  CAS  Google Scholar 

  19. Wainwright MS, Martin PL, Morse RP, Lacaze M, Provenzale JM, Coleman RE et al. Human herpesvirus 6 limbic encephalitis after stem cell transplantation. Ann Neurol 2001; 50: 612–619.

    Article  CAS  Google Scholar 

  20. Singh N, Paterson DL . Encephalitis caused by human herpesvirus-6 in transplant recipients: relevance of a novel neurotropic virus. Transplantation 2000; 69: 2474–2479.

    Article  CAS  Google Scholar 

  21. Gentile G . Post-transplant HHV-6 diseases. Herpes 2000; 7: 24–27.

    PubMed  Google Scholar 

  22. Rapaport D, Engelhard D, Tagger G, Or R, Frenkel N . Antiviral prophylaxis may prevent human herpesvirus-6 reactivation in bone marrow transplant recipients. Transpl Infect Dis 2002; 4: 10–16.

    Article  CAS  Google Scholar 

  23. Tokimasa S, Hara J, Osugi Y, Ohta H, Matsuda Y, Fujisaki H et al. Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation. Bone Marrow Transplant 2002; 29: 595–598.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Cell and Gene Therapy, Baylor College of Medicine and The Methodist Hospital, Houston, TX, USA

    T Vu, G Carrum, G Hutton, H E Heslop, M K Brenner & R Kamble

Authors
  1. T Vu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G Carrum
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G Hutton
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H E Heslop
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M K Brenner
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R Kamble
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R Kamble.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vu, T., Carrum, G., Hutton, G. et al. Human herpesvirus-6 encephalitis following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 39, 705–709 (2007). https://doi.org/10.1038/sj.bmt.1705666

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705666

Keywords

This article is cited by

Search

Advanced search

Quick links